Summary
Addition of highly purified human Interleukin-1 to the culture medium of isolated rat islets of Langerhans for 6 days led to 88% inhibition of glucose-induced insulin-release, reduction of islet contents of insulin and glucagon to 31% and 8% respectively, and disintegration of the islets. These effects were dose-dependent and reproducible when using three different Interleukin-1 preparations. Highly purified human Interleukin-2, Lymphotoxin, Leucocyte Migration Inhibitory Factor and Macrophage Migration Inhibitory Factor were ineffective. These findings suggest that Interleukin-1 may play an important role in the molecular mechanisms underlying autoimmune B-cell destruction leading to Type 1 (insulin-dependent) diabetes mellitus.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Nerup J, Lemmark A, Scott J (1984) Autoimmunity. In: Gupta S, ed: Immunology of clinical and experimental diabetes. Plenum Book Company, New York, pp 351–367
Rocklin RE, Bendtzen K, Greineder D (1980) Mediators of immunity: Lymphokines and monokines. Adv Immunol 29: 55–136
Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J (1985) Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40: 424–429
Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH (1985) Mechanisms of pancreatic islet cell destruction: dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy (in press)
Brunstedt J (1980) Rapid isolation of functionally intact pancreatic islets from mice and rats by Percoll™ gradient centrifugation. Diabete Metab 6: 87–89
Heding L (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8: 260–266
Dinarello CA, Bernheim HA, Cannon JG, LoPreste G, Warner SJC, Webb AC, Anion PE (1985) Purified 35-S-methionine, 3-H-leucine labelled human monocyte interleukin-1 with endogenous pyrogen activity. Brit J Rheumatol 24: 59–64
Dinarello CA, Renfer L, Wolff SM (1977) Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc Nail Acad Sci (USA) 74: 4623–4627
Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA (1984) Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc Natl Acad Sci (USA) 81: 7907–7911
Robb RJ, Kutny RM, Chowdhry V (1983) Purification and partial sequence analysis of human T-cell growth factor. Proc Natl Acad Sci (USA) 80: 5990–5994
Rhodes CJ, Taylor KW (1984) Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets. Diabetologia 27: 601–603
Dinarello CA (1984) Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311: 1413–1418
Bendtzen K (1983) Biological properties of interleukins. Allergy 38:219–226
Giulian D, Lachman LB (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228: 497–499
Like AA, Forster RM, Woda BA, Rossini AA (1983) T-cell subsets in islets and lymphnodes of biobreeding/Worcester (BB/W) rats. Diabetes 32: 201 (Abstract)
Sibley RK, Sutherland DER, Goetz FC, Michael AF (1985) Recurrent diabetes mellitus in the pancreatic iso- and allograft period. A light and electronmicroscopic and immunohistochemical analysis of four cases. Lab Invest 53: 132–144
Debray-Sachs M, Boitard C, Assan R, Hamburger J (1981) Are “activated” macrophages cytotoxic against normal cells? Transpl Proc 13:1111–1113
Schwizer RW, Leiter EH, Evans R (1984) Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. Transplantation 37:539–544
Oschilewski U, Kiesel U, Kolb H (1985) Administration of silica prevents diabetes in BB-rats. Diabetes 34:197–199
Nash JR, Everson NW, Wood RFM, Bell PRF (1980) Effect of silica and carrageenan on the survival of islet allografts. Transplantation 29: 206–208
Prud'homme GJ, Fuks A, Colle E, Seemayer TA, Guttmann RD (1984) Immune dysfunction in diabetes-prone BB-rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages. J Exp Med 159: 463–478
Zier KS, Leo MM, Spielman RS, Baker L (1984) Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes 33: 552–555
Luger A, Schernthaner G, Luger TA (1985) Lymphokine production in insulin-dependent diabetes mellitus. Eur J Clin Invest 15: 1 A (abstract)
Arenzana-Seisdedos FM, Virelizier JL (1983) Interferons as macrophage-activating factors II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 13: 437–440
Bonner-Weir S, Orci L (1982) New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31: 883–889
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mandrup-Poulsen, T., Bendtzen, K., Nerup, J. et al. Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 29, 63–67 (1986). https://doi.org/10.1007/BF02427283
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02427283